MedTrace Logo

MRCP Diagnoses EHCC Better When Combined DWI

NCT01595217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2017-05-16

No results posted yet for this study

Summary

Researching the diagnostic significance of Biliary Tract Neoplasm under combining DWI sequence with MRCP versus MRCP only separately.

Conditions

Interventions

DEVICE

3T MRI

diffusion weighted imaging(DWI) of biliary tract with GE Signa 3-tesla device

Sponsors & Collaborators

  • First Hospital of China Medical University

    collaborator OTHER

  • China Medical University, China

    lead OTHER

Principal Investigators

  • Xiaoping yang, MD · First Affiliated Hospital of China Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-03-31
Completion
2013-05-31
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01595217 on ClinicalTrials.gov